Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...

Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking ...

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular ...

Shares of consumer-products company Kenvue Inc. rose the most in two months after the Wall Street Journal reported that ...

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's plans for Kenvue at an investor conference tomorrow. Shares of Kenvue (KVUE) took off Monday morning on indications ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc KVUE, the company behind popular consumer products like Tylenol and Listerine. Despite having some ...

Activist investor Starboard Value has taken a sizeable stake in Kenvue Inc., the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night. The Wall Street Journal ...